Replies to post #328783 on NorthWest Biotherapeutics Inc (NWBO)

[survivor1x]

With no cross over and based on OS. Sure it would have.

[BioInvestor4]

Doesn’t work that way..

[jammyjames]

well i'm only expecting a reasonable sized benefit due to the inclusion/exclusion criteria as i've shown before:

http://jammyjames.com/analysis.php

that's before we start taking into account any dilution of signal due to cross-over. I'm hoping it comes out stat sig due to the length of the trial (and that's why they chose to go way past the original designated stop point) and hopefully adapted the testing criteria (again as i've mentioned previously i'm hoping the new SAP includes something like a fleming-harrington(0,1) test instead of a basic logrank test).

so no if that's the case the trial wouldn't have ended.

[biosectinvestor]

I’ve seen your posts elsewhere...

Not true.